International symposium on RWE in drug regulation and HTA
The aim of this symposium is to review the current status of RWE use and to address future directions for the implementation of RWE in decision making of both regulatory and HTA agencies. To this effect, specialist speakers are invited to represent views from academia, regulatory, and HTA agencies.
In recent years, the interest and need for real-world evidence (RWE) has been increasing due to the advent of innovative, yet expensive, pharmaceutical drugs, e.g. in the context of the evidence gaps for rare diseases. Numerous initiatives are undergoing worldwide to assess the potential use of RWE in decision making on drug regulation and health technology assessment (HTA). However, despite such initiatives, it remains unclear if and how decision makers in regulatory agencies and HTA agencies should proceed with the use of RWE in their processes.
Date: May 9, 2018
Venue: Utrecht University Hall, Kanunnikenzaal
Location: Utrecht, the Netherlands
Registration for the symposium is required: https://goo.gl/forms/8meSbj1C2ieGLEtz1
For more information, please visit the following link: